ESSA Pharma changes EPIX stock terms in merger

Published on 10/01/2026 at 14:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

A merger assigns USD 0.1242 and 1.0000 new share per old EPIX share. EPIX stock is tied to the September 30, 2026 merger terms for holders.

EPIX, CA2966881026, Illustration mit AI erstellt.

ESSA Pharma Inc. (CA2966881026) is tied to a cash and stock merger that assigns USD 0.1242 and 1.0000 new share for each old EPIX share, according to Robinhood in its corporate actions tracker dated September 30, 2026. The terms place the corporate action ahead of the company's former clinical-stage profile.

Merger terms reshape EPIX holdings

The consideration combines a fixed cash payment with a one-for-one share exchange. For every old EPIX share, the tracker lists USD 0.1242 and 1.0000 share of EPIX with a caret suffix, while fractional shares are retained, according to Robinhood.

The same tracker lists EPIX as delisted pending a stock liquidation. That status makes the merger mechanics more important than a conventional daily share-price move because the economic outcome depends on the stated cash and share consideration, according to Robinhood.

Company history adds context

ESSA's investor-relations page identifies the company as NASDAQ-listed under EPIX and describes a pipeline centered on small-molecule cancer therapies. The page also records the completion of XenoTherapeutics' acquisition of ESSA on October 9, 2025, in a company announcement available from ESSA Pharma.

The investor page lists year-end financial materials for the fourth quarter of 2023 and names EPI-7386 among the company's oncology development efforts. Those dated materials provide historical context, while the September 30, 2026 corporate action supplies the immediate shareholder reference point.

Corporate action is the key reference

The relevant figures are the USD 0.1242 cash component and the 1.0000 share exchange ratio. Together, they define the stated consideration per old share and explain why the merger terms matter more than a standard trading snapshot for EPIX holders.